These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 24940321)

  • 1. Causes and outcome of hospitalization among HIV-infected adults receiving antiretroviral therapy in Mulago hospital, Uganda.
    Namutebi AM; Kamya MR; Byakika-Kibwika P
    Afr Health Sci; 2013 Dec; 13(4):977-85. PubMed ID: 24940321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A decade of antiretroviral therapy in Uganda: what are the emerging causes of death?
    Kiragga AN; Mubiru F; Kambugu AD; Kamya MR; Castelnuovo B
    BMC Infect Dis; 2019 Jan; 19(1):77. PubMed ID: 30665434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opportunistic diseases diminish the clinical benefit of immediate antiretroviral therapy in HIV-tuberculosis co-infected adults with low CD4+ cell counts.
    Worodria W; Ssempijja V; Hanrahan C; Ssegonja R; Muhofwa A; Mazapkwe D; Mayanja-Kizza H; Reynolds SJ; Colebunders R; Manabe YC
    AIDS; 2018 Sep; 32(15):2141-2149. PubMed ID: 30005014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementation and operational research: Integrated pre-antiretroviral therapy screening and treatment for tuberculosis and cryptococcal antigenemia.
    Pac L; Horwitz MM; Namutebi AM; Auerbach BJ; Semeere A; Namulema T; Schwarz M; Bbosa R; Muruta A; Meya DB; Manabe YC
    J Acquir Immune Defic Syndr; 2015 Apr; 68(5):e69-76. PubMed ID: 25761234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Operationalizing early antiretroviral therapy in HIV-infected in-patients with opportunistic infections including tuberculosis.
    Sunpath H; Edwin C; Chelin N; Nadesan S; Maharaj R; Moosa Y; Smeaton L; Court R; Knight S; Gwyther E; Murphy RA
    Int J Tuberc Lung Dis; 2012 Jul; 16(7):917-23. PubMed ID: 22687498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality & clinical characteristics of hospitalized adult patients with HIV in Pune, India.
    Sobhani R; Basavaraj A; Gupta A; Bhave AS; Kadam DB; Sangle SA; Prasad HB; Choi J; Josephs J; Gebo KA; Morde SN; Bollinger RC; Kakrani AL
    Indian J Med Res; 2007 Aug; 126(2):116-21. PubMed ID: 17932435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease patterns and causes of death of hospitalized HIV-positive adults in West Africa: a multicountry survey in the antiretroviral treatment era.
    Lewden C; Drabo YJ; Zannou DM; Maiga MY; Minta DK; Sow PS; Akakpo J; Dabis F; Eholié SP;
    J Int AIDS Soc; 2014; 17(1):18797. PubMed ID: 24713375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asymptomatic cryptococcal antigen prevalence detected by lateral flow assay in hospitalised HIV-infected patients in São Paulo, Brazil.
    Vidal JE; Toniolo C; Paulino A; Colombo A; Dos Anjos Martins M; da Silva Meira C; Pereira-Chioccola VL; Figueiredo-Mello C; Barros T; Duarte J; Fonseca F; Alves Cunha M; Mendes C; Ribero T; Dos Santos Lazera M; Rajasingham R; Boulware DR
    Trop Med Int Health; 2016 Dec; 21(12):1539-1544. PubMed ID: 27699970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and factors associated with cryptococcal antigenemia among severely immunosuppressed HIV-infected adults in Uganda: a cross-sectional study.
    Oyella J; Meya D; Bajunirwe F; Kamya MR
    J Int AIDS Soc; 2012 Mar; 15(1):15. PubMed ID: 22417404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low uptake of antiretroviral therapy after admission with human immunodeficiency virus and tuberculosis in KwaZulu-Natal, South Africa.
    Murphy RA; Sunpath H; Taha B; Kappagoda S; Maphasa KT; Kuritzkes DR; Smeaton L
    Int J Tuberc Lung Dis; 2010 Jul; 14(7):903-8. PubMed ID: 20550776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cause-specific mortality and the contribution of immune reconstitution inflammatory syndrome in the first 3 years after antiretroviral therapy initiation in an urban African cohort.
    Castelnuovo B; Manabe YC; Kiragga A; Kamya M; Easterbrook P; Kambugu A
    Clin Infect Dis; 2009 Sep; 49(6):965-72. PubMed ID: 19673615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence, incidence and mortality associated with tuberculosis in HIV-infected patients initiating antiretroviral therapy in rural Uganda.
    Moore D; Liechty C; Ekwaru P; Were W; Mwima G; Solberg P; Rutherford G; Mermin J
    AIDS; 2007 Mar; 21(6):713-9. PubMed ID: 17413692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of HIV-positive patients with cryptococcal meningitis in the Americas.
    Crabtree Ramírez B; Caro Vega Y; Shepherd BE; Le C; Turner M; Frola C; Grinsztejn B; Cortes C; Padgett D; Sterling TR; McGowan CC; Person A
    Int J Infect Dis; 2017 Oct; 63():57-63. PubMed ID: 28807740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe sepsis in two Ugandan hospitals: a prospective observational study of management and outcomes in a predominantly HIV-1 infected population.
    Jacob ST; Moore CC; Banura P; Pinkerton R; Meya D; Opendi P; Reynolds SJ; Kenya-Mugisha N; Mayanja-Kizza H; Scheld WM;
    PLoS One; 2009 Nov; 4(11):e7782. PubMed ID: 19907656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and predictors of mortality and the effect of tuberculosis immune reconstitution inflammatory syndrome in a cohort of TB/HIV patients commencing antiretroviral therapy.
    Worodria W; Massinga-Loembe M; Mazakpwe D; Luzinda K; Menten J; Van Leth F; Mayanja-Kizza H; Kestens L; Mugerwa RD; Reiss P; Colebunders R;
    J Acquir Immune Defic Syndr; 2011 Sep; 58(1):32-7. PubMed ID: 21654499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asymptomatic serum cryptococcal antigenemia and early mortality during antiretroviral therapy in rural Uganda.
    Liechty CA; Solberg P; Were W; Ekwaru JP; Ransom RL; Weidle PJ; Downing R; Coutinho A; Mermin J
    Trop Med Int Health; 2007 Aug; 12(8):929-35. PubMed ID: 17697087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk score for predicting mortality including urine lipoarabinomannan detection in hospital inpatients with HIV-associated tuberculosis in sub-Saharan Africa: Derivation and external validation cohort study.
    Gupta-Wright A; Corbett EL; Wilson D; van Oosterhout JJ; Dheda K; Huerga H; Peter J; Bonnet M; Alufandika-Moyo M; Grint D; Lawn SD; Fielding K
    PLoS Med; 2019 Apr; 16(4):e1002776. PubMed ID: 30951533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and outcomes of cryptococcal antigenemia in HIV-seropositive patients hospitalized for suspected tuberculosis in Uganda.
    Andama AO; den Boon S; Meya D; Cattamanchi A; Worodria W; Davis JL; Walter ND; Yoo SD; Kalema N; Haller B; Huang L;
    J Acquir Immune Defic Syndr; 2013 Jun; 63(2):189-94. PubMed ID: 23542636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies to reduce early morbidity and mortality in adults receiving antiretroviral therapy in resource-limited settings.
    Lawn SD; Harries AD; Wood R
    Curr Opin HIV AIDS; 2010 Jan; 5(1):18-26. PubMed ID: 20046144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a national cryptococcal antigen screening program for HIV-infected patients in Uganda: A cost-effectiveness modeling analysis.
    Rajasingham R; Meya DB; Greene GS; Jordan A; Nakawuka M; Chiller TM; Boulware DR; Larson BA
    PLoS One; 2019; 14(1):e0210105. PubMed ID: 30629619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.